190
Participants
Start Date
June 12, 2023
Primary Completion Date
December 30, 2024
Study Completion Date
October 25, 2025
Ruxolitinib Cream
Ruxolitinib cream 1.5% twice daily (BID) during the continuous and open label treatment period.
Vehicle Cream
Ruxolitinib matching vehicle cream 1.5% twice daily (BID) during the vehicle-controlled period.
Clinica Gaias Santiago, Santiago de Compostela
University of Pittsburgh Medical Center Upmc Dermatology Clinic Oakland Falk Medical Building, Pittsburgh
Dermatologische Gemeinschaftspraxis Mahlow, Mahlow
Ajou University Hospital, Suwon
Dermdox Center For Dermatology, Sugarloaf
Fondazione Irccs Ca Granda Ospedale Maggiore, Milan
Chu Dijon-Bourgogne, Dijon
Axon Clinical Research, Baltimore
Hospital Universitario Ramon Y Cajal, Madrid
Hospital Universitario 12 de Octubre, Madrid
Ars - Maitland Clinical Research Unit, Orlando
Bordeaux Chu Hopital Saint - Andre, Bordeaux
Klinikum Bielefeld Rosenhohe Dermatologie, Bielefeld
Hospital Universitario de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria
University of Alabama At Birmingham, Birmingham
Universitatsmedizin Goettingen, Göttingen
Aventiv Research Inc-Dublin, Dublin
Wright State Physicians, Inc., Fairborn
Oakview Dermatology, Athens
The South Bend Clinic Main Campus, South Bend
Universitatsklinikum Munster, Münster
Azienda Ospedaliero Universitaria Pisana - Ospedale S. Chiara, Pisa
Universitatsklinikum Frankfurt, Frankfurt am Main
Hopital Edouard Herrio, Lyon
Northwest Arkansas Clinical Trials Center, Arkansas City
Dermresearch, Inc., Austin
Universita Degli Studi Della Campania Luigi Vanvitelli, Napoli
Chu Amiens - Hopital Sud, Salouël
Centre Hospitalier Universitaire de Poitiers, Poitiers
Dermatology Research Associates, Los Angeles
Clinical Science Institute Clinical Research Specialists Inc, Santa Monica
Cura Clinical Research, Sherman Oaks
Marietta Dermatology the Skin Cancer Center Marietta, Marietta
Activmed Practices Research, Llc Beverly, Beverly
Premier Specialists Pty Ltd, Kogarah
Liverpool Hospital, Liverpool
Holdsworth House Medical Practice, Sydney
Westmead Hospital, Sydney
Veracity Clinical Research, Woolloongabba
The Alfred Hospital, Melbourne
Paratus Clinical Research, Woden, Phillip
Landeskrankenhaus Universitatsklinikum Graz, Graz
Ordensklinikum Linz Gmbh Elisabethinen, Linz
Sozialmedizinisches Zentrum Ost-Donauspital, Vienna
Medical Center Medconsult Pleven Ood, Pleven
Medical Center- Prolet Ltd, Rousse
Medical Center Unimed Eood, Sevlievo
Dcc 'Alexandrovska', Eood, Sofia
Medical Center Hera Eood, Sofia
Umhat Prof. Dr. Stoyan Kirkovich Ad, Stara Zagora
Kingsway Clinical Research, Etobicoke
Lynderm Research Inc, Markham
North York Research Inc., North YORK
Skin Centre For Dermatology, Peterborough
Diex Recherche Quebec Inc., Québec
Herlev Og Gentofte Hospital, Hellerup
Sjaellands Universitetshospital, Roskilde
Chu de Nice - Hospital L Archet, Nice
Azienda Ospedaliera Di Perugia - Ospedale Santa Maria Della Misericordia, Perugia
Azienda Ospedaliera Universitaria Policlinico Tor Vergata, Rome
Diamond Clinic Specjalistyczne Poradnie Lekarskie, Krakow
Dermoklinika Centrum Medyczne S.C., M. Kierstan, J. Narbutt, A. Lesiak, Lodz
Luxderm Specjalistyczny Gabinet Dermatologiczny, Lublin
Centrum Badawcze Panaceum Agnieszka Brzezicka, Magdalena Lenkiewicz Sp. Z O.O., Malbork
Solumed Centrum Medyczne, Poznan
Dermaceum Centrum Badan Klinicznych, Wroclaw
Dermmedica Sp. Z O.O., Wroclaw
Korea University Anam Hospital, Seoul
Seoul National University Hospital, Seoul
Asan Medical Center, Seoul
The Catholic University of Korea Seoul St. Mary'S Hospital, Seoul
Korea University Guro Hospital, Seoul
Ceim Hospital Universitari Germans Trias I Pujol, Badalona
Dermatology & Skin Care Clinic, Buochs
Centre Hospitalier Universitaire Vaudois (Chuv), Lausanne
Universitatsspital Zurich, Zurich-flughafen
Lead Sponsor
Incyte Corporation
INDUSTRY